Novel dual HIV maintenance therapy with nevirapine plus lamivudine retain viral suppression through 144 weeks—A proof-of-concept study

OBJECTIVES: The aim of this proof-of-concept study is to test feasibility and efficacy of NVP plus Lamivudine (3TC) as novel simplified HIV maintenance dual therapy (DT) strategy. METHODS: Patients under combined antiretroviral treatment (cART) with fully suppressed HIV plasma viral load (pVL) >2...

Descripción completa

Detalles Bibliográficos
Autores principales: Kahlert, C. R., Cipriani, M., Vernazza, P.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2020
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7511013/
https://www.ncbi.nlm.nih.gov/pubmed/32966293
http://dx.doi.org/10.1371/journal.pone.0237770

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7511013/
https://www.ncbi.nlm.nih.gov/pubmed/32966293
http://dx.doi.org/10.1371/journal.pone.0237770

Ejemplares similares